Skip to main content
. 2020 May 13;22(9):1524–1532. doi: 10.1038/s41436-020-0826-1

Table 2.

Polyp occurrence in the GI tract.

Index patients Nonindex patients
Totala Total with featureb Totala Total with featureb
n n (% of total) Median age (years)c (IQR) n n (% of total) Median age (years)c (IQR)
JP in stomach 126 35 (27.8%) 40.0 (16.0) 95 23 (24.2%) 42.0 (19.0)
SMAD4 71 28 (39.4%) 40.0 (13.5) 56 21 (37.5%) 41.0 (14.8)
BMPR1A 55 7 (12.7%) 35.5 (28.0) 39 2 (5.1%) 56.5 (11.0)
JP in small intestine 126 13 (10.3%) 24.0 (26.5) 95 10 (10.5%) 46.0 (22.5)
SMAD4 71 10 (14.1%) 29.0 (18.5) 56 10 (17.9%) 46.0 (22.5)
BMPR1A 55 3 (5.5%) 14.0 (30.0) 39 0
JP in colon 126 111 (88.1%) 18.0 (25.0) 95 45 (47.4%) 20.0 (30.8)
SMAD4 71 61 (85.9%) 19.0 (24.5) 56 29 (51.8%) 30.5 (35.0)
BMPR1A 55 50 (90.9%) 18.0 (23.3) 39 16 (41%) 16.0 (31.0)
JP in rectum 126 58 (46.0%) 18.5 (28.0) 95 12 (12.6%) 13.0 (15.0)
SMAD4 71 30 (42.3%) 14.0 (28.8) 56 7 (12.5%) 6.0 (11.8)
BMPR1A 55 28 (50.9%) 19.0 (27.8) 39 5 (12.8%) 15.0 (22.0)
Other types of polypsd 126 58 (46.0%) 23.0 (23.0) 95 25 (26.3%) 40.0 (29.0)
SMAD4 71 30 (42.3%) 23.0 (24.0) 56 16 (28.6%) 42.0 (25.0)
BMPR1A 55 28 (50.9%) 23.0 (20.5) 39 9 (23.1%) 31.0 (41.0)

GI gastrointestinal, IQR interquartile range, JP juvenile polyp.

aTotal number of patients.

bTotal number of index or nonindex patients who presented with the respective symptom.

cDue to missing age at diagnosis the calculation of the median age is often based on fewer than the total number of patients with the respective feature.

dAdenomas, serrated and other polyps.